Cargando…

The FDA-Approved Essure Device Counseling Order Fails to Promote Patient Empowerment

Detalles Bibliográficos
Autores principales:	Gunn, Christine M., Paasche-Orlow, Michael K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SLACK Incorporated 2019
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607766/ https://www.ncbi.nlm.nih.gov/pubmed/31289791 http://dx.doi.org/10.3928/24748307-20190306-01

Ejemplares similares

Challenges in Removing the Essure(®) Device
por: van Gastel, Daniëlle M., et al.
Publicado: (2020)

The current landscape of the FDA approved companion diagnostics
por: Jørgensen, Jan Trøst
Publicado: (2021)

First vaccine approval under the FDA Animal Rule
por: Beasley, David W C, et al.
Publicado: (2016)

An insider's perspective on FDA approval of aducanumab
por: Wang, Yaning
Publicado: (2023)

The approval and withdrawal of melphalan flufenamide (melflufen): Implications for the state of the FDA.
por: Olivier, Timothée, et al.
Publicado: (2022)

Drugs, Devices, and the FDA: Part 2: An Overview of Approval Processes: FDA Approval of Medical Devices
por: Van Norman, Gail A.
Publicado: (2016)

Safety reporting of Essure medical device: a qualitative and quantitative assessment on the FDA manufacturer and user facility device experience database in 2018
por: Zou, Chenyu, et al.
Publicado: (2023)

Pharmacogenetic Labeling of FDA-Approved Drugs: A Regulatory Retrospective
por: Drozda, Katarzyna, et al.
Publicado: (2018)

Mendelian Randomization Studies Promise to Shorten the Journey to FDA Approval
por: Roberts, Robert
Publicado: (2018)

Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies
por: Constantinescu, Catalin, et al.
Publicado: (2020)

Quality of life after laparoscopic removal of Essure(®) sterilization devices
por: Chene, Gautier, et al.
Publicado: (2019)

Essure Microinsert Abdominal Migration after Hysteroscopic Tubal Sterilization of an Appropriately Placed Essure Device: Dual Case Reports and Review of the Literature
por: Rezai, Shadi, et al.
Publicado: (2015)

Comment on ‘End of the road for Essure®?’
por: Das, Sayantana, et al.
Publicado: (2018)

Essure(®) removal in 10 steps
por: Chene, Gautier, et al.
Publicado: (2021)

Intracavitary deposits on Essure® hysteroscopic sterilization devices: A case report
por: Maassen, L.W., et al.
Publicado: (2017)

FDA expedited approval and implications for rational formulary and health plan design
por: Ferries, Erin A, et al.
Publicado: (2021)

A Novel Technique for Essure Reversal
por: Clark, Nisse V., et al.
Publicado: (2019)

Endometrial fluid associated with Essure implants placed before in vitro fertilization: Considerations for patient counseling and surgical management
por: Sills, E Scott, et al.
Publicado: (2015)

Challenges and opportunities for improving access to approved neonatal drugs and devices
por: Lewis, Tamorah, et al.
Publicado: (2022)

Drugs, Devices, and the FDA: Part 1: An Overview of Approval Processes for Drugs
por: Van Norman, Gail A.
Publicado: (2016)

FDA Approvals of Biologics in 2022
por: Martins, Alexander C., et al.
Publicado: (2023)

Efficacy, safety, and patient acceptability of the Essure™ procedure
por: Lessard, Collette R, et al.
Publicado: (2011)

Initial experience with hysteroscopic tubal occlusion (Essure(®))
por: Depes, Daniella De Batista, et al.
Publicado: (2016)

Recall Rates of Total Knee Arthroplasty Devices Are Dependent on the FDA Approval Process
por: Pellerin, Carl, et al.
Publicado: (2020)

Why Did the FDA Approve These Advertisements?
por: Oaks, David
Publicado: (2006)

FDA approved ready to use phenylephrine
por: Bhatia, Pradeep Kumar, et al.
Publicado: (2021)

Alchemical analysis of FDA approved drugs
por: Orsi, Markus, et al.
Publicado: (2023)

The Nordic perspective on migration and empowerment
por: Dahl, Berit Misund, et al.
Publicado: (2020)

Letter to the Editor: Metal hypersensitivity reactions in the context of Essure™
por: Markel, Kory, et al.
Publicado: (2018)

Factors Associated with Negative Patient Experiences with Essure Sterilization
por: van Limburg Stirum, Emilie V. J., et al.
Publicado: (2020)

FDA efficiency for approval process of COVID-19 therapeutics
por: Cassidy, Christine, et al.
Publicado: (2020)

The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database
por: Benjamens, Stan, et al.
Publicado: (2020)

FDA-Approved Amoxapine Effectively Promotes Macrophage Control of Mycobacteria by Inducing Autophagy
por: Wang, Jia, et al.
Publicado: (2022)

Redefining Genomic Privacy: Trust and Empowerment
por: Erlich, Yaniv, et al.
Publicado: (2014)

Social Media and the Patient – on Education and Empowerment
por: Zamora, Geraldine T.
Publicado: (2022)

FDA approved drugs as potential Ebola treatments
por: Ekins, Sean, et al.
Publicado: (2015)

FDA-approved medications that impair human spermatogenesis
por: Ding, Jiayi, et al.
Publicado: (2016)

FDA approved antibacterial drugs: 2018-2019
por: Andrei, Stefan, et al.
Publicado: (2019)

FDA-Approved Oximes and Their Significance in Medicinal Chemistry
por: Dhuguru, Jyothi, et al.
Publicado: (2022)

Timeline of FDA-Approved Targeted Therapy for Cholangiocarcinoma
por: Cho, Su Min, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sa5o2e07ssr1p74cmovm499nq8